Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Cytokine Release Syndrome
Related studies linked through entity extraction aliases.
Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy
- Status
- RECRUITING
- Phase
- NA
Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study
- Status
- RECRUITING
- Phase
- PHASE1
Pre-emptive Anakinra for Cytokine Event Reduction
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab
- Status
- RECRUITING
- Phase
- PHASE1
Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy
- Status
- RECRUITING
- Phase
- N/A
Jafron Haemoadsorption During Cardiopulmonary Bypass
- Status
- COMPLETED
- Phase
- PHASE2
PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19
- Status
- UNKNOWN
- Phase
- PHASE3
Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Tocilizumab and Cytokine Release Syndrome (CRS) In Covid-19 Pneumonia
- Status
- COMPLETED
- Phase
- N/A
Cyclosporine on Day Zero as Prophylaxis for Cytokine Release Syndrome
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Tolerability Study of IV ST266 in COVID-19 Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Anakinra in the Management of COVID-19 Infection
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Influence of Cytosorb on Amount of Catecholamine and Mortality in Sepsis
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan
- Status
- COMPLETED
- Phase
- NA